In the seventeen month time period of this retrospective study, there were 11,719 HBsAg tests ordered for 9,930 patients (with some patients being tested two or more separate times during the time ...
1 Department of Biomedical and Public Health, Research Institute for Health Sciences (IRSS), Ouagadougou, Burkina Faso. 2 Pietro Annigoni Biomolecular Research Centre (CERBA), Ouagadougou, Burkina ...
In clinical trials, bepirovirsen showed the potential to address a significant unmet medical need for patients with chronic hepatitis B by reducing hepatitis B surface antigen levels and HBV DNA. The ...
Hepatitis B is a viral infection that impacts the liver. To test for hepatitis B, a doctor can perform a blood test that detects hepatitis B surface antigens. A positive result indicates a hepatitis B ...
Stroke is a leading cause of mortality and permanent disability in China, with large and unexplained geographic variations in rates of different stroke types. Chronic hepatitis B virus infection is ...
Background: Discontinuation of antiviral therapy in chronic hepatitis B (CHB) patients leads to a higher hepatitis B surface antigen (HBsAg) loss; yet, clinical relapse (CR) may occur. SCALE-B score ...
Copyright: © 2022 The Author(s). Published by Elsevier Ltd. We observed an HBsAg seroprevalence ranging from 2.6% in blood donors to 8.0% in HIV-infected patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback